ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA March 2019 PDF-final.pdf

Drug Safety Update MHRA March 2019 PDF-final.pdf
Summary: Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Onivyde (irinotecan, liposomal formulations): reports of serious and fatal thromboembolic events. Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
File Size: 388KB
File Type: application/pdf
Created: 25 March 2019
Last Modified: 25 March 2019